» Articles » PMID: 36705286

Relationships Between Headache Frequency, Disability, and Disability-related Unemployment Among Adults with Migraine

Overview
Specialties Pharmacology
Pharmacy
Date 2023 Jan 27
PMID 36705286
Authors
Affiliations
Soon will be listed here.
Abstract

Migraine is the second most common cause of disability worldwide. Understanding the relationship between migraine and employment status is critical for policymakers, as disability-related unemployment is associated with eligibility for private or governmental disability insurance payments and other associated support for those unable to work because of disability. To assess the association between migraine frequency and selfreported employment status and overall disability in a US representative survey. Using data from the 2019 National Health and Wellness Survey (NHWS) (Kantar Health), adults in the United States (aged 18-65 years) reporting at least 1 migraine day in the past 30 days were categorized by headache frequency: low-frequency episodic migraine (LFEM) (≤4 days/month), moderate-frequency EM (MFEM) (5-9 days/month), high-frequency EM (HFEM) (10-14 days/month), or chronic migraine (CM) (≥15 days/month). A control group of adults without migraine with similar baseline characteristics was identified by propensity score matching. Disability-related unemployment was defined as participants responding "short-term disability" or "long-term disability" to occupational status on the NHWS. The frequency of short- or long-term disability was then evaluated across headache frequency groups. In addition, participants were asked to assess migraine-related disability via the Migraine Disability questionnaire (MIDAS). A total of 1,962 respondents with LFEM, 987 with MFEM, 554 with HFEM, and 926 with CM were included in this analysis, along with 4,429 matched controls. Headache frequency was associated both with increased MIDAS score and with employment disability ( < 0.001); 12.3% (n = 114 of 926) of participants with CM reported employment disability, as did 4.4% (n = 86 of 1,962) of the LFEM group and 6.9% (n = 306 of 4,429) of matched controls. There was considerable discordance between the proportion of participants classified as disabled via MIDAS vs those reporting employment-related disability. More frequent migraine headaches are associated with a higher likelihood of self-reported short- and long-term employment disability and overall migraine-related disability, suggesting that health and economic policymakers must seek ways to maximize the employment opportunities for people living with migraine that may benefit from novel preventive treatments. Robert E Shapiro is a research consultant for Eli Lilly and Lundbeck. Ashley A Martin and Martine C Maculaitis are employees of Cerner Enviza (formerly Kantar Health), which received payment from Lundbeck to conduct the research. Shiven Bhardwaj was an employee of Lundbeck at the time of study and manuscript development. Heather Thomson and Carlton Anderson are employees of Lundbeck. Steven M Kymes is an employee and stockholder of Lundbeck. Financial support for research conducted and manuscript preparation was provided by Lundbeck.

Citing Articles

Stigmatizing attitudes toward people with migraine by people without active migraine: results of the OVERCOME (US) study.

Shapiro R, Viktrup L, Muenzel E, Buse D, Zagar A, Ashina S BMC Neurol. 2025; 25(1):103.

PMID: 40075330 PMC: 11899170. DOI: 10.1186/s12883-025-04039-1.


Functional Disability and Psychological Impact in Headache Patients: A Comparative Study Using Conventional Statistics and Machine Learning Analysis.

Kim J, Kim H, Sohn J, Hwang S, Lee J, Kwon Y Medicina (Kaunas). 2025; 61(2).

PMID: 40005305 PMC: 11857184. DOI: 10.3390/medicina61020188.


Risk of Attempted and Completed Suicide in Persons Diagnosed With Headache.

Elser H, Farkas D, Fuglsang C, Sorensen S, Sorensen H JAMA Neurol. 2025; 82(3):276-284.

PMID: 39899309 PMC: 11791769. DOI: 10.1001/jamaneurol.2024.4974.


Hallmarks of primary headache: part 1 - migraine.

Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G J Headache Pain. 2024; 25(1):189.

PMID: 39482575 PMC: 11529271. DOI: 10.1186/s10194-024-01889-x.


First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients.

Yang Z, Wang X, Niu M, Wei Q, Zhong H, Li X J Headache Pain. 2024; 25(1):160.

PMID: 39333875 PMC: 11438109. DOI: 10.1186/s10194-024-01873-5.


References
1.
Yang M, Wang P, Wang S, Sun W, Oyang Y, Fuh J . Women with endometriosis are more likely to suffer from migraines: a population-based study. PLoS One. 2012; 7(3):e33941. PMC: 3307779. DOI: 10.1371/journal.pone.0033941. View

2.
DAmico D, Tepper S, Guastafierro E, Toppo C, Leonardi M, Grazzi L . Mapping Assessments Instruments for Headache Disorders against the ICF Biopsychosocial Model of Health and Disability. Int J Environ Res Public Health. 2021; 18(1). PMC: 7795912. DOI: 10.3390/ijerph18010246. View

3.
Agosti R . Migraine Burden of Disease: From the Patient's Experience to a Socio-Economic View. Headache. 2018; 58 Suppl 1:17-32. DOI: 10.1111/head.13301. View

4.
Borkum J, Evans R . Disability and chronic migraine. Headache. 2014; 54(4):719-25. DOI: 10.1111/head.12339. View

5.
Hu X, Markson L, Lipton R, Stewart W, Berger M . Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999; 159(8):813-8. DOI: 10.1001/archinte.159.8.813. View